SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PINOTTI, Mirko
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.239
EU - Europa 3.291
AS - Asia 2.754
OC - Oceania 13
SA - Sud America 9
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 18.318
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.192
CN - Cina 1.296
IT - Italia 882
UA - Ucraina 715
SG - Singapore 679
DE - Germania 567
TR - Turchia 473
GB - Regno Unito 308
PL - Polonia 203
FI - Finlandia 190
SE - Svezia 165
ID - Indonesia 133
BE - Belgio 73
CA - Canada 44
FR - Francia 40
VN - Vietnam 33
CZ - Repubblica Ceca 31
IN - India 29
HK - Hong Kong 27
NL - Olanda 27
RU - Federazione Russa 26
IR - Iran 17
JP - Giappone 17
AU - Australia 11
KR - Corea 11
NO - Norvegia 11
RO - Romania 11
DK - Danimarca 10
CH - Svizzera 9
BR - Brasile 8
GE - Georgia 8
IQ - Iraq 8
TW - Taiwan 8
PT - Portogallo 6
LT - Lituania 5
AT - Austria 3
ES - Italia 3
EU - Europa 3
IE - Irlanda 3
IL - Israele 3
PK - Pakistan 3
ZA - Sudafrica 3
KE - Kenya 2
MX - Messico 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
CR - Costa Rica 1
LU - Lussemburgo 1
MA - Marocco 1
MT - Malta 1
PH - Filippine 1
Totale 18.318
Salva come PNG Salva come JPEG
Città #
Fairfield 1.429
Woodbridge 1.423
Chandler 991
Houston 915
Jacksonville 812
Ann Arbor 719
Ashburn 684
Seattle 598
Wilmington 555
Singapore 546
Santa Clara 509
Cambridge 474
Ferrara 350
Izmir 307
Nanjing 255
Princeton 231
Beijing 214
Warsaw 202
New York 150
Boardman 149
Shanghai 142
San Diego 132
Jakarta 131
Milan 125
Dearborn 109
Bremen 105
Nanchang 83
Shenyang 71
Brussels 66
Los Angeles 63
Falls Church 60
Jiaxing 57
Redwood City 54
Tianjin 48
Hebei 45
Changsha 44
Jinan 42
San Mateo 37
Mountain View 35
Helsinki 34
London 34
Toronto 34
Dong Ket 33
Kunming 30
Norwalk 30
Bologna 29
Des Moines 28
Guangzhou 27
Auburn Hills 24
Ningbo 24
Brno 23
Munich 20
Zhengzhou 20
Padova 19
Washington 18
Orange 17
Monmouth Junction 16
Frankfurt am Main 15
Indiana 14
Hong Kong 13
Rome 13
Augusta 12
Düsseldorf 12
Hangzhou 12
Leawood 12
Florence 11
Hefei 10
Taizhou 10
Ferrara di Monte Baldo 9
Paris 9
Piemonte 9
Copenhagen 8
Naples 8
Oslo 8
Ottawa 8
Philadelphia 8
Andover 7
Baghdad 7
Hounslow 7
Olomouc 7
Redmond 7
Verona 7
Addison 6
Chicago 6
Fuzhou 6
Rochester 6
Taipei 6
Espoo 5
Lanzhou 5
Tokyo 5
Trieste 5
Alexandria 4
Amsterdam 4
Ardabil 4
Calvisano 4
Castagnole delle Lanze 4
Catania 4
Chengdu 4
Clifton 4
Falkenstein 4
Totale 13.751
Salva come PNG Salva come JPEG
Nome #
Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy 188
An exon-specific U1snRNA induces a robust factor IX activity in mice expressing multiple human FIX splicing mutants 180
Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides 176
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 168
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 166
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 158
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 154
Mcl-1 involvement in mitochondrial dynamics is associated with apoptotic cell death 152
Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca 2+ levels and tumor growth 150
Molecular Basis and Therapeutic Strategies to Rescue Factor IX Variants That Affect Splicing and Protein Function 148
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 146
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 145
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 144
Nuove strategie per la veicolazione di acidi nucleici: nanosistemi cationici a matrice lipidica 141
Chronic sleep deprivation markedly reduces coagulation factor VII expression 138
Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based Therapeutics 138
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations 137
The dominant-negative von Willebrand factor gene deletion p.P1127-C1948delinsR: Molecular mechanism and modulation 131
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 128
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 128
A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates. 127
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 126
Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant 125
Cationic lipid nanosystems as carriers for nucleic acids 124
Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation 123
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 123
Circadian rhythms in mouse blood coagulation 121
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 121
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 121
An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects 120
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 119
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 119
Variation of factor VII 140s and 170s loops in fishes: evolutionary aspects and comparison with mutations found in FVII deficiency 118
Temporal variations of coagulation factor VII activity in mice are influenced by lighting regime 117
Major differences in bleeding symptoms between factor VII deficiency and hemophilia B 117
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII 117
Membrane binding and anticoagulant properties of protein S natural variants 116
Ribosome readthrough accounts for secreted full-length factor IX in hemophilia B patients with nonsense mutations 116
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 116
Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. 114
Residual factor VII activity and different hemorrhagic phenotypes in CRM+ factor VII deficiencies (Gly331Ser and Gly283Ser) 114
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 114
Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity 113
Detection and characterization of polymorphic markers in the factor-VII gene. 113
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 112
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 111
Cationic lipid nanosystems as carriers for nucleic acids 111
Rescue of coagulation factor VII function by the U1+5A snRNA 110
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 109
Factor VII mutant V154G models a zymogen-like form of factor VIIa 108
RNA-based therapeutic approaches for coagulation factor deficiencies 108
Characterization of anti-coagulant properties of prenylated coumarin ferulenol. 107
Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis 107
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 106
A unique exon specific U1snRNA rescues different haemophilia B - causing splicing-defective factor IX variants in mice 106
An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A 106
Attività sulla emostasi di alcune piante della medicina tradizionale indiana 105
Polymorphic changes in the 5' flanking region of factor VII have a combined effect on promoter strength 105
Impaired prothrombinase activity of factor X Gly381 Asp results in severe familial CRM+ FX deficiency 105
Evidence for an overlapping role of clock and npas2 transcription factors in liver circadian oscillators 105
Intracellular evaluation of ER targeting elucidates a mild form of inherited coagulation deficiency 105
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 105
The carboxyl-terminal region of human coagulation factor X as a natural linker for fusion strategies 105
Molecular mechanisms of FVII deficiency: expression of mutations clustered in the IVS7 donor splice site of factor VII gene. 102
Modulation of factor VII levels by intron 7 polymorphisms: Population and in vitro studies 102
Promoter methylation in coagulation F7 gene influences plasma FVII concentrations and relates to coronary artery disease. 101
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 101
The complete impairment of factor VII gene expression by the IVS6+1g/t mutation is compatible with a severe but not lethal bleeding disorder 101
Characterization of the intracellular signalling capacity of natural FXa mutants with reduced pro-coagulant activity 101
Next-generation sequencing and recombinant expression characterized aberrant splicing mechanisms and provided correction strategies in factor VII deficiency 100
Modulation of factor V levels in plasma by polymorphisms in the C2 domain 99
The factor V Glu1608Lys mutation is recurrent in familial thrombophilia 98
Altered mRNA processing and FVIII biosynthesis/function as determinants of phenotype variability in the frequent Arg2016Trp Haemophilia A patients. 98
Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectors 98
Replacement of the Y450 (c234) phenyl ring in the carboxyl-terminal region of coagulation factor IX causes pleiotropic effects on secretion and enzyme activity 97
Exon-specific U1 snRNAs improve ELP1 exon 20 definition and rescue ELP1 protein expression in a familial dysautonomia mouse model 97
1,3,8-Triazaspiro[4.5]decane Derivatives Inhibit Permeability Transition Pores through a FO-ATP Synthase c Subunit Glu119-Independent Mechanism That Prevents Oligomycin A-Related Side Effects 96
Nanosistemi lipidici per la veicolazione di acidi nucleici 96
Disease-causing variants of the conserved+2T of 5 ' splice sites can be rescued by engineered U1snRNAs 96
Management of Kidney Transplantation in a Factor VII-Deficient Patient: Case Report 96
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition 96
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 95
Gentamicin induces sub-therapeutic levels of coagulation factor VII in patients with nonsense mutations 95
Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations. 94
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 94
null 94
Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7) 94
Activation of Endoplasmic Reticulum Stress and Unfolded Protein Response in Congenital Factor VII Deficiency 94
Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effect 94
Protein S mRNA in patients with protein S deficiency. 93
null 93
Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency 91
In-Frame Deletion of von Willebrand Factor Exons 26-34 (D3-A3 Domains) in Type II von Willebrand Disease. 90
Correction of aberrant splicing causing haemophilia B through the combination of compensatory U1snRNAs and antisense oligonucleotides 90
The somatic FAH C.1061C>A change counteracts the frequent FAH c.1062+5G>A mutation and permits U1snRNA-based splicing correction 90
Release of Tissue Factor-bearing microparticles by human dendritic cells induced by stimulation of membrane P2X7 receptors 89
Gene therapy-based prophylaxis to rescue the "prima ballerina" 89
null 87
null 86
Rescue of spinal muscular atrophy mouse models with AAV9-Exon-specific U1 snRNA 85
Totale 11.418
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.919
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 581
Totale 93.500
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.315 0 0 0 0 267 475 329 369 312 331 160 72
2020/20212.796 202 160 147 290 96 242 231 330 131 454 366 147
2021/20222.248 137 262 114 73 113 104 112 106 80 187 185 775
2022/20232.359 261 184 73 301 409 315 135 179 276 15 128 83
2023/20241.269 110 140 79 45 79 210 50 77 36 48 40 355
2024/20251.653 175 117 507 179 675 0 0 0 0 0 0 0
Totale 18.785